PHVS earnings: real EPS beat/miss history, analyst consensus Buy, P/E -10.64. Updated 2026-07-23.
Pharvaris (PHVS) Research Hub
Pharvaris (PHVS) trades on NASDAQ, NL in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 38.02 USD (+0.74%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -10.64, market cap 2.40B. This hub links to the full technical, earnings and options research available for PHVS.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, NL |
| Last close | 38.02 USD (+0.74%) |
| 52-week range | 30.49 USD – 43.25 USD |
| Trend regime | Range |
| 14-day RSI | 64.9 (Bullish) |
| Trailing P/E | -10.64 |
| Market cap | 2.40B |
| Dividend yield | 0.00% |
Available research for PHVS
Covered Call on PHVS: how it works, illustrative setup around the real 38.02 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PHVS: how it works, illustrative setup around the real 38.02 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PHVS: how it works, illustrative setup around the real 38.02 USD price, max profit/loss, breakeven and when to use it. Educational.
PHVS technical analysis: range, last 38.02 USD, RSI 64.9, 52w range 30.49 USD–43.25 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is PHVS in?
Pharvaris (PHVS) is classified under Healthcare (Biotechnology), listed on NASDAQ, NL.
Is PHVS in an uptrend or downtrend?
As of 2026-09-11, PHVS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PHVS's trailing P/E ratio?
PHVS's trailing P/E is -10.64, with a market cap of 2.40B. See the earnings research page for full valuation detail.